This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
This guide covers withdrawal-friendly total market ETFs and how to structure distributions to maximize cash flow while controlling taxes in retirement.
28,154 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
NVIDIA unveiled an AI Compute Partnership aimed at financing AI cloud capacity, potentially transforming Nvidia from ...
Samsung Electronics and several Korean firms pushed back on Open USD participation claims, saying they had no formal ...
Bitcoin hovers near $70,000 as Iran-driven energy volatility cools and policy expectations shift, setting up a pivota...
SoFi faces a fragile mix of improving profitability and credit risk as growth opportunities widen. This analysis weig...
The Federal Reserve unveiled five task forces led by academics and business leaders to reevaluate policy decision-mak...
Beijing and Hong Kong unveiled a coordinated package to deepen offshore yuan liquidity and gold settlement, signaling...
Oil prices hover near $87 per barrel in early July 2026 trading as markets digest supply and demand dynamics. This ar...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
JPMorgan Chase delivered a record-breaking second quarter in 2026, topping expectations across the board. CEO Jamie D...
New York City unveils a plan to force disclosure of AI-edited rental photos, part of a broader tenant-protection pack...
Palantir has surprised and divided investors with big moves and bold AI promises. This guide explains what to watch, ...